van Mourik JA - Search Results

1

Identification of a binding site for blood coagulation factor IXa on the light chain of human factor VIII.

Lenting PJ, Donath MJ, van Mourik JA, Mertens K. Lenting PJ, et al. Among authors: van mourik ja. J Biol Chem. 1994 Mar 11;269(10):7150-5. J Biol Chem. 1994. PMID: 8125924 Free article.

2

Phospholipid-binding domain of factor VIII is involved in endothelial cell-mediated activation of factor X by factor IXa.

Brinkman HJ, Mertens K, van Mourik JA. Brinkman HJ, et al. Among authors: van mourik ja. Arterioscler Thromb Vasc Biol. 2002 Mar 1;22(3):511-6. doi: 10.1161/hq0302.105359. Arterioscler Thromb Vasc Biol. 2002. PMID: 11884299

3

Cleavage at arginine 145 in human blood coagulation factor IX converts the zymogen into a factor VIII binding enzyme.

Lenting PJ, ter Maat H, Clijsters PP, Donath MJ, van Mourik JA, Mertens K. Lenting PJ, et al. Among authors: van mourik ja. J Biol Chem. 1995 Jun 23;270(25):14884-90. doi: 10.1074/jbc.270.25.14884. J Biol Chem. 1995. PMID: 7797466 Free article.

4

The role of cleavage of the light chain at positions Arg1689 or Arg1721 in subunit interaction and activation of human blood coagulation factor VIII.

Donath MS, Lenting PJ, van Mourik JA, Mertens K. Donath MS, et al. Among authors: van mourik ja. J Biol Chem. 1995 Feb 24;270(8):3648-55. doi: 10.1074/jbc.270.8.3648. J Biol Chem. 1995. PMID: 7876103 Free article.

5

The activation of human blood coagulation factor X on the surface of endothelial cells: a comparison with various vascular cells, platelets and monocytes.

Brinkman HJ, Mertens K, Holthuis J, Zwart-Huinink LA, Grijm K, van Mourik JA. Brinkman HJ, et al. Among authors: van mourik ja. Br J Haematol. 1994 Jun;87(2):332-42. doi: 10.1111/j.1365-2141.1994.tb04918.x. Br J Haematol. 1994. PMID: 7947276

6

Biological activity of recombinant factor VIII variants lacking the central B-domain and the heavy-chain sequence Lys713-Arg740: discordant in vitro and in vivo activity.

Mertens K, Donath MJ, van Leen RW, de Keyzer-Nellen MJ, Verbeet MP, Klaasse Bos JM, Leyte A, van Mourik JA. Mertens K, et al. Among authors: van leen rw, van mourik ja. Br J Haematol. 1993 Sep;85(1):133-42. doi: 10.1111/j.1365-2141.1993.tb08656.x. Br J Haematol. 1993. PMID: 8251380

7

The sequence Glu1811-Lys1818 of human blood coagulation factor VIII comprises a binding site for activated factor IX.

Lenting PJ, van de Loo JW, Donath MJ, van Mourik JA, Mertens K. Lenting PJ, et al. Among authors: van de loo jw, van mourik ja. J Biol Chem. 1996 Jan 26;271(4):1935-40. doi: 10.1074/jbc.271.4.1935. J Biol Chem. 1996. PMID: 8567641 Free article.

8

Enhanced thrombin sensitivity of a factor VIII-heparin cofactor II hybrid.

Voorberg J, van Stempvoort G, Bos JM, Mertens K, van Mourik JA, Donath MJ. Voorberg J, et al. Among authors: van stempvoort g, van mourik ja. J Biol Chem. 1996 Aug 30;271(35):20985-8. doi: 10.1074/jbc.271.35.20985. J Biol Chem. 1996. PMID: 8702860 Free article.

9

Kinetics of factor VIII light-chain cleavage by thrombin and factor Xa. A regulatory role of the factor VIII heavy-chain region Lys713-Arg740.

Donath MJ, Lenting PJ, Van Mourik JA, Mertens K. Donath MJ, et al. Among authors: van mourik ja. Eur J Biochem. 1996 Sep 1;240(2):365-72. doi: 10.1111/j.1432-1033.1996.0365h.x. Eur J Biochem. 1996. PMID: 8841400 Free article.

10

Dissimilar interaction of factor VIII with endothelial cells and lipid vesicles during factor X activation.

Brinkman HJ, Koster P, Mertens K, van Mourik JA. Brinkman HJ, et al. Among authors: van mourik ja. Biochem J. 1997 May 1;323 ( Pt 3)(Pt 3):735-40. doi: 10.1042/bj3230735. Biochem J. 1997. PMID: 9169607 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

176 results

Search Page

Filters